OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
Covered by 2 sources
Read full post
Miles Wang, an OpenAI researcher known for AI-driven scientific discovery, is leaving to start a drug discovery AI startup. The company is reportedly in talks to raise $200M at a $2B valuation, with Lightspeed as a potential lead investor. The startup aims to repurpose existing drugs using AI, accelerating drug development timelines.
